[O4] Oral Presentations 4 | AMED SCARDA「ワクチン開発のための世界トップレベル研究開発拠点の形成事業」合同シンポジウム

詳細検索

セッション詳細

口頭発表

[O4]Oral Presentations 4

2025年3月18日(火) 10:15 〜 11:45

神戸国際会議場　メインホール(1F)

Presentations 7 - 9 in this session are candidates for the Oral Presentation Award for Early-career Researchers.

10:15 〜 10:25

[O4-01]Genetic factors to determine COVID-19 vaccine titers

Kyuto Sonehara^1,2,3, Yoshifumi Uwamino⁴, Koichi Matsuda¹, Ho Namkoong⁴, *Yukinori Okada^1,2,3 (1. The University of Tokyo (Japan), 2. Osaka University (Japan), 3. RIKEN Center for Integrative Medical Sciences (Japan), 4. Keio University (Japan))

10:25 〜 10:35

[O4-02]Rational design of lipid nanoparticle-mRNA vaccine with reduced reactogenicity and preserved immunogenicity through immune profiling

*松村隆之¹
*Takayuki Matsumura¹, Tomohiro Takano¹, Yoshimasa Takahashi¹ (1. Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases (Japan))

10:35 〜 10:45

[O4-03]Development of optimized inactivated whole virus particle vaccine for COVID-19

*Marumi Ohno¹, Toshiki Sekiya¹, Richard Obeng-Kyeremeh¹, Chimuka Handabile¹, Minori Haruta¹, Naoki Nomura¹, Tomomi Kawakita¹, Masashi Shingai¹, Hiroshi Kida¹ (1. International Institute for Zoonosis Control, Hokkaido University (Japan))

10:45 〜 10:55

[O4-04]AI-assisted surveillance and vaccine design

*Ken J ISHII^1,2, Burcu Temizoz^1,2, Tomoya Hayashi^1,2, Hideo Negishi^1,2, Kouji Kobiyama^1,2 (1. The Institute of Medical Science, The University of Tokyo (Japan), 2. International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo (Japan))

10:55 〜 11:05

[O4-05]M2KO Influenza Vaccines for Achieving Broader Immunity

*Yoshihiro Kawaoka¹ (1. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA) (Japan))

11:05 〜 11:15

[O4-06]Pandemic preparedness with vaccine.

*Hideki Hasegawa^1,2 (1. Research Center of Influenza and Respiratory Viruses, National Institute of Infectious Diseases (Japan), 2. Institute for Vaccine Research and Development, Hokkaido University (Japan))

11:15 〜 11:25Candidate for the Oral Presentation Award for Early-career Researchers

[O4-07E]Confidential

*Koto Hattori¹, Rika Nakahashi^1,2, Yohei Uchida¹, Yuhei Nogami¹, Hiroshi Kiyono^1,2,3,4,5 (1. Department of Human Mucosal Vaccinology, Chiba University Hospital (Japan), 2. Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University (Japan), 3. Future Medicine Education and Research Organization, Chiba University (Japan), 4. Department of Medicine, UC San Diego School of Medicine (United States of America), 5. CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines, UC San Diego School of Medicine (United States of America))

11:25 〜 11:35Candidate for the Oral Presentation Award for Early-career Researchers

[O4-08E]A novel nucleic acid vaccine delivery system “Nano-ball” for efficient immune induction

*Tomoaki Kurosaki¹, Shusaku Mizukami², Kenji Hirayama², Kouichi Morita², Hitoshi Sasaki² (1. Graduate School of Biomedical Sciences, Nagasaki University (Japan), 2. Institute of Tropical Medicine, Nagasaki University (Japan))

11:35 〜 11:45Candidate for the Oral Presentation Award for Early-career Researchers

[O4-09E]Confidential

*Seiki Shirai^1,2,3 (1. Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan (Japan), 2. Vaccine R&D Laboratory, Vaccine Business Division, Shionogi & Co., Ltd. (Japan), 3. Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba, Japan (Japan))

カテゴリ一覧へ戻る